Cyclic oxygen analogues of alkyl-lysophospholipids. Synthesis and neoplastic cell growth inhibitory properties. 1990

W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
Sandoz Research Institute, East Hanover, NJ 07936.

Ether phospholipids have demonstrated both in vitro and in vivo activity against a wide variety of tumor cell lines. The known cyclic ether phospholipid, SRI 62-834, was used as the model to prepare eight novel phospholipids containing a cyclic ether. All of the compounds were as effective as ET-18-OCH3 in their ability to activate macrophage-induced cytotoxicity against the Abelson-8.1 tumor cell line but varied in their direct cytotoxic effects. One of the new compounds, SDZ 62-406, was selected for in vivo studies and showed oral and i.v. activity in the mouse MethA fibrosarcoma model in the same range as ET-18-OCH3. No correlation was found between the direct or macrophage-activated cytotoxicity and the ability of the compounds to inhibit or promote platelet-activating factor (PAF)-induced aggregation of human platelets.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D010742 Phospholipid Ethers Phospholipids which have an alcohol moiety in ethereal linkage with a saturated or unsaturated aliphatic alcohol. They are usually derivatives of phosphoglycerols or phosphatidates. The other two alcohol groups of the glycerol backbone are usually in ester linkage. These compounds are widely distributed in animal tissues. Ether Phosphatidates,Ether Phospholipids,Glycerol Phosphate Ethers,Glycerophosphate Ethers,1-Alkyl-2-Acylphosphatidates,1 Alkyl 2 Acylphosphatidates,Ethers, Glycerol Phosphate,Ethers, Glycerophosphate,Ethers, Phospholipid,Phosphate Ethers, Glycerol,Phosphatidates, Ether,Phospholipids, Ether
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012513 Sarcoma, Experimental Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA. EHS Tumor,Sarcoma, Engelbreth-Holm-Swarm,Sarcoma, Jensen,Experimental Sarcoma,Experimental Sarcomas,Sarcomas, Experimental,Engelbreth-Holm-Swarm Sarcoma,Jensen Sarcoma,Sarcoma, Engelbreth Holm Swarm,Tumor, EHS
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
October 1986, Journal of medicinal chemistry,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
June 1990, Journal of medicinal chemistry,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
December 1994, Anti-cancer drug design,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
September 2012, Journal of peptide science : an official publication of the European Peptide Society,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
November 1987, Lipids,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
December 1974, Nucleic acids research,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
October 1977, Journal of medicinal chemistry,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
April 2008, Journal of applied microbiology,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
March 2022, The Journal of organic chemistry,
W J Houlihan, and M L Lee, and P G Munder, and C M Winslow, and S H Cheon, and F J D'Aries, and A K DeLillo, and C S Jaeggi, and R B Mason, and V A Parrino
December 2004, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!